Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Corporate Update

14 Sep 2009 07:00

RNS Number : 9502Y
Tarsus Group PLC
14 September 2009
 



14 September 2009

Tarsus Group plc

Corporate Update

Tarsus Group plc ('Tarsus' or 'the Group' or 'the Company'), the international business-to-business media group, is pleased to announce the following corporate update for the period since the announcement of its record interim results on 29th July 2009..

France

The Group has disposed of its 50% shareholding in MD Management SAS to its joint venture partner, Reed Exhibitions France, for a net cash consideration of £ 0.4 million. 

This transaction has resulted in a small book profit and continues the strategy of rationalising the Group's portfolio to focus on larger events, with established brands, which tend to be more resilient throughout the economic cycle.

China

Tarsus has entered into an agreement with its joint venture partner Hubei Hope to invest together a further RMB 10 million (approximately £ 0.9 million) of cash into their joint venture, Tarsus Hope.

The monies will be used to fund acquisitions and new launches in the joint venture's core exhibition sectors of medical equipment and industrial equipment in Central China. The investment is conditional on Chinese regulatory approval, but marks a further step in the development of the Group's portfolio of events in one of the fastest growing exhibition markets in the world.

Trading

The Group's second half exhibitions have begun well, with the Off-Price Show in Las Vegas in August and the Medical event in San Jose in September both now currently trading slightly ahead of management's previous expectations.

Importantly, revenues for the two largest exhibitions in Tarsus' portfolio, Labelexpo Europe in September and the Dubai Airshow in November, continue to remain comfortably ahead of the comparable events in 2007. 

Douglas Emslie, Group Managing Director, said:

"We continue to execute against our strategy of increasing our business in the faster growing emerging markets while actively managing our portfolio in our mature markets.

 Trading for the Group for the full year continues to be in line with the Board's expectations and we anticipate a very satisfactory outcome for 2009."

For further information please contact:

Tarsus Group plc

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

Media

Matthew Moth, Madano Partnership 020 7593 4000

Investor Relations

Neville Harris, IR Focus 020 7593 4015

Stephen ScottJeremy Wiseman, Scott Harris 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLBMITMMTBBLL
Date   Source Headline
12th Jan 20187:00 amRNSTrading Update & launch of next phase of strategy
29th Dec 201710:03 amRNSTotal Voting Rights
13th Dec 20173:22 pmRNSScrip Dividend Circular (the "Circular")
5th Dec 201711:45 amRNSHolding(s) in Company
30th Nov 201710:33 amRNSTotal Voting Rights and Capital
21st Nov 20177:00 amRNSCapital Markets Seminar and Trading Update
14th Nov 20177:00 amRNSSite visit to Dubai Airshow
9th Nov 201710:41 amRNSBlock Listing Six Monthly Return
2nd Nov 20177:00 amRNSChange of Advisers
12th Oct 20177:00 amRNSTrading Statement
26th Sep 20177:00 amRNSAnalyst and Investor Site Visit
22nd Sep 20173:55 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSExpansion of Mexican Joint Venture
6th Sep 201711:38 amRNSBlock Listing Six Monthly Return
31st Aug 20179:31 amRNSTotal Voting Rights
29th Aug 20173:31 pmRNSDirector/PDMR Shareholding
16th Aug 20174:07 pmRNSHalf-year Report
2nd Aug 20171:38 pmRNSDirector/PDMR Shareholding
31st Jul 20172:42 pmRNSTotal Voting Rights
27th Jul 20175:05 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSHalf-year Report
11th Jul 201712:42 pmRNSApplication for Admission
30th Jun 20174:09 pmRNSTotal Voting Rights
21st Jun 201712:13 pmRNSResult of AGM
5th Jun 201711:24 amRNSScrip Dividend Circular
31st May 201710:09 amRNSTotal Voting Rights
19th May 20171:42 pmRNSNotice of AGM
18th May 201712:05 pmRNSHolding(s) in Company
17th May 20177:00 amRNSTrading Update
9th May 20172:45 pmRNSBlock Listing Six Monthly Return
28th Apr 201711:05 amRNSTotal Voting Rights
4th Apr 20175:17 pmRNSHolding(s) in Company
4th Apr 20175:16 pmRNSDirector/PDMR Shareholding
31st Mar 201710:37 amRNSTotal Voting Rights
30th Mar 20176:10 pmRNSDirector/PDMR Shareholding
17th Mar 20172:01 pmRNS2016 Annual Report
16th Mar 20172:29 pmRNSDirector/PDMR Shareholding
15th Mar 20178:41 amRNSHolding(s) in Company
6th Mar 20175:45 pmRNSDirector/PDMR Shareholding
6th Mar 20175:44 pmRNSDirector/PDMR Shareholding
1st Mar 20174:04 pmRNSApplication for Block Listing
1st Mar 20177:00 amRNSFinal Results
8th Feb 201712:19 pmRNSDirector Declaration
1st Feb 201712:02 pmRNSTotal Voting Rights
25th Jan 20177:00 amRNSCompletion of acquisition
17th Jan 201711:14 amRNSApplication for Admission
10th Jan 20177:00 amRNSYear-end Trading Update
30th Dec 20169:03 amRNSTotal Voting Rights
22nd Dec 20167:12 amRNSAcquisition of Hometex
14th Dec 20163:26 pmRNSScript Dividend Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.